Parathyroid Hormone in Osteoporosis Treatment
Parathyroid hormone stimulates bone formation, prevents or reverses bone loss, increases bone mass, bone strength and provides protection against fractures. PTH treatment for postmenopausal, male and glucocorticoid- induced osteoporosis proved to be effective in a number of RCTs.
Main Author: | İ. Özkul |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2002-03-01
|
Series: | Türk Osteoporoz Dergisi |
Online Access: | http://www.turkosteoporozdergisi.org/article_4174/Parathyroid-Hormone-In-Osteoporosis-Treatment |
Similar Items
-
Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women.
by: Lundkvist, J, et al.
Published: (2006) -
Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis
by: Richard G. Pearson, et al.
Published: (2019-06-01) -
Human parathyroid peptide treatment of vertebral osteoporosis.
by: Reeve, J, et al.
Published: (1993) -
Recombinant human parathyroid hormone related protein 1-34 and 1-84 and their roles in osteoporosis treatment.
by: Hua Wang, et al.
Published: (2014-01-01) -
Impact of vitamin D deficiency on fluctuation of calcium and parathyroid hormone levels in postmenopausal osteoporosis
by: Tatjana Milivojac, et al.
Published: (2015-06-01)